Meeder Asset Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,922
Closed -$135K 979
2024
Q3
$135K Buy
4,922
+4,207
+588% +$115K 0.01% 260
2024
Q2
$17.5K Buy
+715
New +$17.5K ﹤0.01% 546
2023
Q1
Sell
-843
Closed -$12.2K 761
2022
Q4
$12.2K Buy
843
+726
+621% +$10.5K ﹤0.01% 635
2022
Q3
$2K Buy
117
+73
+166% +$1.25K ﹤0.01% 1832
2022
Q2
$1K Buy
44
+1
+2% +$23 ﹤0.01% 2036
2022
Q1
$1K Buy
+43
New +$1K ﹤0.01% 2215
2021
Q4
Sell
-3,681
Closed -$118K 1912
2021
Q3
$118K Buy
3,681
+3,144
+585% +$101K 0.01% 857
2021
Q2
$16K Sell
537
-242
-31% -$7.21K ﹤0.01% 1536
2021
Q1
$23K Buy
779
+737
+1,755% +$21.8K ﹤0.01% 1363
2020
Q4
$1K Sell
42
-3,518
-99% -$83.8K ﹤0.01% 1697
2020
Q3
$46K Sell
3,560
-555
-13% -$7.17K ﹤0.01% 972
2020
Q2
$47K Buy
+4,115
New +$47K ﹤0.01% 935
2020
Q1
Sell
-1,041
Closed -$28K 2456
2019
Q4
$28K Sell
1,041
-762
-42% -$20.5K ﹤0.01% 1237
2019
Q3
$52K Buy
+1,803
New +$52K ﹤0.01% 1007
2019
Q2
Sell
-34
Closed -$1K 2101
2019
Q1
$1K Sell
34
-1,237
-97% -$36.4K ﹤0.01% 1631
2018
Q4
$37K Sell
1,271
-5,061
-80% -$147K ﹤0.01% 890
2018
Q3
$290K Sell
6,332
-561
-8% -$25.7K 0.02% 445
2018
Q2
$258K Buy
6,893
+3,674
+114% +$137K 0.02% 470
2018
Q1
$95K Sell
3,219
-1,991
-38% -$58.8K 0.01% 555
2017
Q4
$179K Buy
5,210
+1,918
+58% +$65.9K 0.02% 474
2017
Q3
$119K Buy
3,292
+3,010
+1,067% +$109K 0.01% 539
2017
Q2
$7K Buy
282
+2
+0.7% +$50 ﹤0.01% 1095
2017
Q1
$5K Buy
280
+169
+152% +$3.02K ﹤0.01% 1079
2016
Q4
$2K Buy
+111
New +$2K ﹤0.01% 934